News from aidsmap

Gay men get less HIV but more STIs after starting PrEP, meta-analysis finds

A meta-analysis of 17 studies of HIV pre-exposure prophylaxis (PrEP) in gay men and other men who have sex with men (MSM) has found that, while PrEP protected them from HIV, the proportion diagnosed with gonorrhoea, chlamydia or syphilis increased significantly in the period between starting PrEP and follow-up, with an average length of time on PrEP at follow-up of six months.

Read more >>

Healthcare providers missing opportunities to prescribe PrEP to patients at high risk of HIV

Healthcare providers are missing opportunities to prescribe pre-exposure prophylaxis (PrEP) to patients at high risk of HIV, according to US research published in Clinical Infectious Diseases.

Read more >>

It’s not just HIV stigma – sexism, racism and poverty stigma commonly reported by women living with HIV in the United States

Women living with HIV perceive many forms of stigma in addition to HIV-related stigma, according to a qualitative study published in the July edition of Social Science & Medicine. Stigma related to living with HIV intersected with stigma associated with gender, race, poverty, incarceration and obesity, according to the interviewees.

Read more >>

Rapid change in Australian gay men’s safer sex practices, from consistent condom use to PrEP

A rapid increase in pre-exposure prophylaxis (PrEP) use by gay men in Melbourne and Sydney has been accompanied by an equally rapid decrease in consistent condom use, according to an article published online in The Lancet HIV. The changes in behaviour between 2016 and 2017 occurred across the gay community, not only in PrEP users – a significant increase in condomless sex with casual partners was observed in HIV-negative men who were not taking PrEP.

Read more >>

Hepatitis B or raised liver enzymes predict liver toxicity when TB prevention drug is combined with HIV treatment

The risk of liver toxicity in people with HIV taking antiretroviral therapy and isoniazid preventive therapy for tuberculosis is strongly associated with either hepatitis B co-infection or pre-existing liver enzyme elevations, according to international research published in the 1 May edition of the Journal of Acquired Immune Deficiency Syndromes.

Read more >>

HIV-negative gay men uncomfortable relying on an undetectable viral load to prevent HIV

Australian HIV-negative gay men express far more confidence in pre-exposure prophylaxis (PrEP) than an undetectable viral load in preventing HIV, with only 18% agreeing that “a person with an undetectable viral load cannot pass on HIV” and 6% feeling comfortable having condomless sex with an HIV-positive partner who had an undetectable viral load, according to a pair of articles recently published in Sexually Transmitted Infections and AIDS and Behavior.

Read more >>

Many young MSM discontinue PrEP

A third of young men who have sex with men (MSM) who take pre-exposure prophylaxis (PrEP) discontinue it within a six-month period, investigators from the United States report in AIDS and Behavior. Common reasons for stopping included being unable to get an appointment with a doctor and problems with insurance coverage.

Read more >>

Kidney function declines faster in men on HIV treatment than for their HIV-negative peers

Loss of kidney function in men with HIV is most strongly associated with antiretroviral therapy, an 11-year study of men living with HIV and their HIV-negative counterparts has found. The study found that men with HIV lost twice as much of their kidney function each year as men without HIV – although the average rate of loss was less than 1% a year.

Read more >>

Potential interactions between ART and other medications present in over half of older HIV-positive people

Over half of older HIV-positive people are at risk of experiencing an interaction between their anti-HIV drugs and medications taken for the treatment of non-HIV-related conditions, Italian investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes.

Read more >>

Editors' picks from other sources

Is the world ready for long-acting HIV treatment?

from The Body Pro

"As we look at this question [of] where do long-acting antiretrovirals fit into the armamentarium," commented Carl Dieffenbach, the director of the Division of AIDS within the National Institute of Allergy and Infectious Diseases, "we have to ask ourselves the question: What problems are long-acting or sustained-release formulations solving, and what problems or concerns are the introduction of these type of formulations actually creating?"

Swedish Court decriminalises unprotected sex for HIV-positive people on therapy

from Sputnik News

In a precedent-setting ruling, the Supreme Court of Sweden ruled that "thorough treatment" minimised the risk of infection, thus making a dent in the divulgence requirement for HIV-positive people before having unprotected sex.

Cuts to sexual health services in England imminent

from BBC

Some sexual health clinics face closure or reduced hours as almost half the councils in England plan to cut spending, a BBC investigation reveals. Of the 151 councils that responded to a BBC Freedom of Information request, 72 planned to cut sexual health funding in 2018-19 compared with 2017-18.

500 days and Trump administration absent on HIV

from I'm Still Josh

It has been 500 days since Donald Trump became President of the United States. And it has been 500 days since The White House had any substantial leadership working on behalf of the HIV epidemic or talking prevention strategies. And the blame for that must be shared by us all.

With TV ads, drugmaker Gilead brings HIV prevention drug out of the closet

from NBC News

In a major shift, pharmaceutical giant Gilead Sciences will begin airing television ads for PrEP, its HIV prevention medication. The company said the ads, which will start in June and run through August, are “designed to encourage candid conversations around sexual health and promote public awareness of HIV prevention.”

The US has an HIV epidemic – and its victims are gay black men

from The Guardian

There is an epidemic of HIV/AIDS in the United States, and the reason you may not have heard about it is because of who it harms: black men who have sex with other men. When I give lectures on AIDS, I will often tell incredulous audiences early in my presentation that one in every two gay and bisexual men in the US are projected to become HIV positive in their lifetime. Later, I tell them that, more specifically, the Centers for Disease Control predicts one in every two black gay and bisexual men is projected to become HIV positive in his lifetime if current trends continue.